Literature DB >> 22217297

Dual diagnosis and suicide risk in a Spanish outpatient sample.

Nestor Szerman1, Jorge Lopez-Castroman, Francisco Arias, Consuelo Morant, Francisco Babín, Beatriz Mesías, Ignacio Basurte, Pablo Vega, Enrique Baca-García.   

Abstract

The present study compares dual-diagnosis patients with other groups of psychiatric patients to determine the differential characteristics in suicide risk and other clinical variables between them. During 2008 in Madrid, 837 outpatients were evaluated in addiction and mental health services. Three comparison groups were created according to current diagnosis: (i) dual patients, (ii) patients with substance use disorders but no other mental disorders, and (iii) patients with mental disorders but no substance use disorders. A multinomial logistic regression model was built to explore the risk associated with dual diagnosis. Criteria for dual diagnosis were met at the time of the study by 440 patients (52.6%). Dual patients showed several demographic and clinical differences and a higher risk for suicide than the other two comparison groups. Further research is needed to define suicide preventive strategies for dual patients.

Entities:  

Mesh:

Year:  2012        PMID: 22217297     DOI: 10.3109/10826084.2011.636135

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  6 in total

1.  Managing dual disorders: a statement by the Informal Scientific Network, UN Commission on Narcotic Drugs.

Authors:  Nora D Volkow; Marta Torrens; Vladimir Poznyak; Elizabeth Sáenz; Anja Busse; Wataru Kashino; Dzmitry Krupchanka; Devora Kestel; Giovanna Campello; Gilberto Gerra
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

2.  A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment.

Authors:  Ignacio Basurte-Villamor; Pablo Vega; Carlos Roncero; José Martínez-Raga; Lara Grau-López; Lourdes Aguilar; Marta Torrens; Nestor Szerman
Journal:  Neuropsychiatr Dis Treat       Date:  2022-05-04       Impact factor: 2.989

3.  Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.

Authors:  Ana Adan; Julia E Marquez-Arrico; Gail Gilchrist
Journal:  Health Qual Life Outcomes       Date:  2017-10-23       Impact factor: 3.186

4.  Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study.

Authors:  Beatriz Puértolas-Gracia; María Gabriela Barbaglia; Mercè Gotsens; Oleguer Parés-Badell; María Teresa Brugal; Marta Torrens; Lara Treviño; Concepción Rodríguez-Díaz; José María Vázquez-Vázquez; Alicia Pascual; Marcela Coromina-Gimferrer; Míriam Jiménez-Dueñas; Israel Oliva; Erick González; Nicanor Mestre; Montse Bartroli
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

5.  Professionals' perceptions about healthcare resources for co-occuring disorders in Spain.

Authors:  Carlos Roncero; Pablo Vega; Jose Martínez-Raga; Carmen Barral; Ignacio Basurte-Villamor; Laia Rodríguez-Cintas; Beatriz Mesías; Lara Grau-López; Miguel Casas; Nestor Szerman
Journal:  Int J Ment Health Syst       Date:  2014-08-28

6.  Professionals' perception on the management of patients with dual disorders.

Authors:  Carlos Roncero; Néstor Szerman; Antonio Terán; Carlos Pino; José María Vázquez; Elena Velasco; Marta García-Dorado; Miguel Casas
Journal:  Patient Prefer Adherence       Date:  2016-09-19       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.